Construction and immunogenicity of attenuated Salmonella typhimurium stably harbouring DNA vaccine against Newcastle disease virus.
- Author:
Zhi-Ming PAN
1
;
Jin-Lin HUANG
;
Ning-Ning CHENG
;
Yi-Chen CUI
;
Meng YOU
;
Li-Hua TANG
;
Xiao-Ming ZHANG
;
Xin-An JIAO
;
Xiu-Fan LIU
Author Information
1. Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou 225009, China. pzmshq@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Animals;
Chickens;
Female;
Immunization;
Mice;
Mice, Inbred BALB C;
Newcastle disease virus;
immunology;
Plasmids;
Salmonella typhimurium;
genetics;
Vaccines, Attenuated;
immunology;
Vaccines, DNA;
immunology;
Viral Vaccines;
immunology
- From:
Chinese Journal of Virology
2008;24(1):41-46
- CountryChina
- Language:Chinese
-
Abstract:
The fusion protein (F) gene of Newcastle disease virus was amplified by polymerase chain reaction (PCR) from the recombinant plasmid pVAX1-F, and subcloned into eukaryotic expression vector pmcDNA3. 1+. The F gene was identified by sequencing. The recombinant plasmid was transformed into attenuated Salmonella typhimurium SL7207, and the recombinant was designated as SL7207 (pmcDNA3. 1-F). In vitro and in vivo experiments showed that the plasmid stability of pmcDNA3. 1-F was apparently higher than that of pcDNA3. 1-F in SL7207. In order to compare the immune response induced by these two re combinant bacteria, BALB/c mice were immunized orally with them at the dosage of 2 x 10(9) CFU respectively. Both SL7207(pcDNA3. 1-F) and SL7207(pmcDNA3. 1-F) initiated F-specific serum and mucosal antibodies in immunized mice. Furthermore, 4-day-old SPF chickens were immunized with SL7207(pcDNA3. 1-F) and SL7207(pmcDNA3. 1-F) at the dosage of 5 x 10(9) CFU and boosted two weeks later with the same dosage. Humoral and intestinal mucosal immune responses were observed and their levels were significantly higher than that of negative and positive controls. The result of protective efficacy showed that the chickens immunized with SL7207(pmcDNA3. 1-F) had the protective rate of 70.0%, higher than that of the SL7207 (pcDNA3. 1-F) with 50.0%. In summary, the DNA vaccine delivered by attenuated Salmonella typhimurium has good immunogenicity. A novel mucosal DNA vaccine has been developed and could be useful for controlling the infection and epidemic of Newcastle disease in the poultry.
